Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-900
Closed -$25.8K 12983
2025
Q1
$25.8K Hold
900
﹤0.01% 12943
2024
Q4
$40.3K Sell
900
-5,500
-86% -$260K ﹤0.01% 12607
2024
Q3
$283K Sell
6,400
-400
-6% -$16.4K ﹤0.01% 9458
2024
Q2
$263K Buy
6,800
+400
+6% +$16.4K ﹤0.01% 9402
2024
Q1
$313K Sell
6,400
-14,100
-69% -$677K ﹤0.01% 9365
2023
Q4
$992K Buy
20,500
+14,100
+220% +$628K ﹤0.01% 6701
2023
Q3
$259K Sell
6,400
-10,000
-61% -$396K ﹤0.01% 9429
2023
Q2
$647K Sell
16,400
-800
-5% -$29K ﹤0.01% 7376
2023
Q1
$701K Buy
17,200
+12,700
+282% +$467K ﹤0.01% 7566
2022
Q4
$149K Buy
+4,500
New +$135K ﹤0.01% 10616
2022
Q3
Sell
-14,500
Closed -$416K 12789
2022
Q2
$416K Sell
14,500
-12,800
-47% -$486K ﹤0.01% 9063
2022
Q1
$1.42M Buy
27,300
+10,500
+63% +$539K ﹤0.01% 6873
2021
Q4
$1.13M Buy
16,800
+4,300
+34% +$309K ﹤0.01% 7643
2021
Q3
$910K Buy
+12,500
New +$919K ﹤0.01% 8394

Other funds holding DCBO

Citadel Advisors's DCBO Position: Q1 2026 in Review

Citadel Advisors sold out of Docebo (DCBO) in Q1 2026, closing a stake of 23,115 shares — an estimated $513K sold.

Citadel Advisors first reported a position in DCBO in Q1 2021 and held it in 19 quarters. The position peaked at $5.04M in Q2 2024. 67 funds tracked by Wall St. Rank hold DCBO as of Q1 2026.

  • Citadel Advisors reported no remaining Docebo position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 23,115 Docebo shares in Q1 2026, an estimated $513K.
  • Citadel Advisors first reported a position in Docebo in Q1 2021 and held it in 19 quarters.
  • Citadel Advisors's Docebo position peaked at $5.04M in Q2 2024.
  • 67 funds tracked by Wall St. Rank held Docebo as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.